Gu Kong
Impact in
- Cancer Research top 0.2%
- Cancer Genomics and Diagnostics
- Cancer-related molecular mechanisms research
- Breast Cancer Treatment Studies
- Oncology top 0.5%
- Lung Cancer Research Studies
- Cancer Immunotherapy and Biomarkers
Papers in
-
- Cancer Genomics and Diagnostics 19
- Oncology 17
- Cancer Cells and Metastasis 6
- HER2/EGFR in Cancer Research 4
- Cancer-related Molecular Pathways 3
- Co-authors
- Jeong‐Yeon Lee (16 shared papers)Mi-Ock Lee (10 shared papers)Heekyoung Chung (14 shared papers)Young‐Gun Yoo (2 shared papers)Seok Jin Nam (8 shared papers)Hee‐Young Won (8 shared papers)Young‐Ha Oh (8 shared papers)Myeong Hee Moon (4 shared papers)
- Journals
- Nature Communications (13 papers)Nature (8 papers)Cancer Letters (7 papers)Oncogene (7 papers)Nature Genetics (6 papers)
- Partner nations
- South KoreaUnited StatesCanada
In The Last Decade
Gu Kong
129 papers receiving 18.4k citations
Gu Kong's Hit Papers
Peers
Comparison fields: 5 of 119
- Cancer Research 3.5k
- Oncology 2.3k
- Molecular Biology 2.8k
- Geriatrics and Gerontology 116
- Genetics 868
Countries citing papers authored by Gu Kong
This map shows the geographic impact of Gu Kong's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gu Kong with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gu Kong more than expected).
Fields of papers citing papers by Gu Kong
This network shows the impact of papers produced by Gu Kong. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gu Kong. The network helps show where Gu Kong may publish in the future.
Co-authors
The 25 scholars most cited alongside Gu Kong, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 129 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | The repertoire of mutational signatures in human cancer Hit paper breakdown → | 2020 | 2401 |
| 2 | Pan-cancer analysis of whole genomes Hit paper breakdown → | 2020 | 2169 |
| 3 | Comprehensive genomic profiles of small cell lung cancer Hit paper breakdown → | 2015 | 1840 |
| 4 | Landscape of somatic mutations in 560 breast cancer whole-genome sequences Hit paper breakdown → | 2016 | 1681 |
| 5 | HRDetect is a predictor of BRCA1 and BRCA2 deficiency based on mutational signatures Hit paper breakdown → | 2017 | 798 |
| 6 | The evolutionary history of 2,658 cancers Hit paper breakdown → | 2020 | 730 |
| 7 | Patterns of somatic structural variation in human cancer genomes Hit paper breakdown → | 2020 | 564 |
| 8 | Comprehensive analysis of chromothripsis in 2,658 human cancers using whole-genome sequencing Hit paper breakdown → | 2020 | 489 |
| 9 | Analyses of non-coding somatic drivers in 2,658 cancer whole genomes Hit paper breakdown → | 2020 | 428 |
| 10 | Genomic portrait of resectable hepatocellular carcinomas: Implications of RB1 and FGF19 aberrations for patient stratification Hit paper breakdown → | 2014 | 354 |
| 11 | Comprehensive molecular characterization of mitochondrial genomes in human cancers Hit paper breakdown → | 2020 | 319 |
| 12 | Pan-cancer analysis of whole genomes identifies driver rearrangements promoted by LINE-1 retrotransposition Hit paper breakdown → | 2020 | 315 |
| 13 | Genomic basis for RNA alterations in cancer Hit paper breakdown → | 2020 | 310 |
| 14 | 1999 | 297 | |
| 15 | The landscape of viral associations in human cancers Hit paper breakdown → | 2020 | 293 |
| 16 | 2016 | 203 | |
| 17 | 2020 | 190 | |
| 18 | 2006 | 181 | |
| 19 | 2015 | 176 | |
| 20 | 2008 | 168 |
About Gu Kong
Gu Kong is a scholar working on Cancer Research, Oncology, Pharmacology, Molecular Biology and Pharmacology, having authored 129 papers that have together received 18.7k indexed citations. Recurring topics across this work include Cancer Genomics and Diagnostics (19 papers), Drug-Induced Hepatotoxicity and Protection (8 papers), Cancer Cells and Metastasis (6 papers), Epigenetics and DNA Methylation (5 papers), Metabolomics and Mass Spectrometry Studies (5 papers), Inflammatory mediators and NSAID effects (4 papers), HER2/EGFR in Cancer Research (4 papers) and Cancer-related Molecular Pathways (3 papers). The work is most often cited by research in Cancer Research (3.5k citations), Oncology (2.3k citations), Molecular Biology (2.8k citations), Geriatrics and Gerontology (116 citations) and Genetics (868 citations). Gu Kong has collaborated with scholars based in South Korea, United States and Canada. Frequent co-authors include Jeong‐Yeon Lee, Mi-Ock Lee, Heekyoung Chung, Young‐Gun Yoo, Seok Jin Nam, Hee‐Young Won, Young‐Ha Oh, Myeong Hee Moon, Mi Kyung Kim and Kyung‐Sun Kang. Their work appears in journals such as Nature Communications, Nature, Cancer Letters, Oncogene and Nature Genetics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.